What Nymox Pharmaceutical Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Robinson James George | Director | Apr 27 | Open-market buy · P | +40,000 | $0.47 | +$18.8K | 4,782,065 |
| Robinson James George | Director | Apr 25 | Open-market buy · P | +40,000 | $0.45 | +$18K | 4,742,065 |
| Robinson James George | Director | Apr 25 | Open-market buy · P | +40,000 | $0.45 | +$18K | 4,742,065 |
| Robinson James George | Director | May 02 | Open-market buy · P | +1,151,515 | $1.65 | +$1.9M | 4,702,065 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +200 | $2.09 | +$417 | 3,550,550 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +1,100 | $2.09 | +$2.3K | 3,550,350 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +2,900 | $2.09 | +$6.06K | 3,549,250 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +800 | $2.10 | +$1.68K | 3,546,350 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +51 | $2.08 | +$106 | 3,545,550 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +4,949 | $2.09 | +$10.3K | 3,545,499 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +5,000 | $2.05 | +$10.3K | 3,540,550 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +3,100 | $2.11 | +$6.53K | 3,535,550 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +1,900 | $2.13 | +$4.05K | 3,532,450 |
| Robinson James George | Director | Apr 22 | Open-market buy · P | +7,000 | $2.07 | +$14.5K | 3,530,550 |
| Robinson James George | Director | Apr 21 | Open-market buy · P | +900 | $2.08 | +$1.87K | 3,523,550 |
| Robinson James George | Director | Apr 21 | Open-market buy · P | +4,100 | $2.08 | +$8.53K | 3,522,650 |
| Robinson James George | Director | Apr 21 | Open-market buy · P | +6,000 | $2.08 | +$12.5K | 3,518,550 |
| Robinson James George | Director | Apr 21 | Open-market buy · P | +2,000 | $2.09 | +$4.18K | 3,512,550 |
| Robinson James George | Director | Jul 10 | Open-market buy · P | +100 | $1.72 | +$172 | 3,510,550 |
| Robinson James George | Director | Jul 10 | Open-market buy · P | +166 | $1.73 | +$287 | 3,510,450 |
Loading...